Guannan Shu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling Suppression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 19, 2025
Retraction Note: N6 -methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 18, 2025
Lactylation-related gene signature as a prognostic biomarker for neuroblastoma: insights into tumor progression and immune modulation.
Journal: Cell & bioscience
Published: February 10, 2025
STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis.
Journal: Cell death & disease
Published: October 07, 2024
N6-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 20, 2024
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.
Journal: Cancer letters
Published: October 31, 2023
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition.
Journal: Journal for immunotherapy of cancer
Published: September 07, 2023
EGCG-LYS Fibrils-Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 20, 2023
Last Updated: 09/26/2026